newsfilter
← Latest News
GlobeNewswire·

Exagen to Announce Third Quarter Financial Results on November 10, 2026

  • Exagen Inc. (NASDAQ: XGN) will release Q3 2026 financial results before the market opens on November 10, 2026.
  • CEO John Aballi & CFO Jeff Black will host a webcast at 8:00 a.m. ET (5:00 a.m. PT) to review the results.
  • The live webcast & a 12-month replay will be accessible via investors.exagen.com.
  • Phone participants must register in advance using the provided link to receive dial-in instructions.
  • Exagen operates a CLIA-certified, CAP-accredited laboratory in San Diego County, California, focusing on autoimmune diagnostics.
  • The company's flagship test, AVISE ® CTD, aids in diagnosing complex conditions such as lupus, rheumatoid arthritis, & Sjögren's disease.